Journal of Genetic Syndromes & Gene Therapy · 2013 · 110 citations · 116 references
MedicineCancer BiologyOncologyApoptosisGene TherapyMolecular OncologyApoptosis In CancerCell DeathCytotoxic ChemotherapyProgrammed Cell DeathTargeted Cancer TherapyTargeted TherapyCancer Cell ApoptosisCell Death In CancerGene-targeted TherapyHerpes Simplex Virus VectorsIntracellular TargetsTargeted Gene TherapyViral Expression VectorsViral Vectors
Current cancer treatments may create profound iatrogenic outcomes. The adverse effects of these treatments still remain, as the serious problems that practicing physicians have to cope with in clinical practice. Although, non-specific cytotoxic agents constitute an effective treatment modality against cancer cells, they also tend to kill normal, quickly dividing cells. On the other hand, therapies targeting the genome of the tumors are both under investigation, and some others are already streamlined to clinical practice. Several approaches have been investigated in order to find a treatment targeting the cancer cells, while not affecting the normal cells. Suicide gene therapy is a therapeutic strategy, in which cell suicide inducing transgenes are introduced into cancer cells. The two major suicide gene therapeutic strategies currently pursued are: cytosine deaminase/5-fluorocytosine and the herpes simplex virus/ganciclovir. The novel strategies include silencing gene expression, expression of intracellular antibodies blocking cells' vital pathways, and transgenic expression of caspases and DNases. We analyze various elements of cancer cells' suicide inducing strategies including: targets, vectors, and mechanisms. These strategies have been extensively investigated in various types of cancers, while exploring multiple delivery routes including viruses, non-viral vectors, liposomes, nanoparticles, and stem cells. We discuss various stages of streamlining of the suicide gene therapy into clinical oncology as applied to different types of cancer. Moreover, suicide gene therapy is in the center of attention as a strategy preventing cancer from developing in patients participating in the clinical trials of regenerative medicine. In oncology, these clinical trials are aimed at regenerating, with the aid of stem cells, of the patients' organs damaged by pathologic and/or iatrogenic factors. However, the stem cells carry the risk of neoplasmic transformation. We discuss cell suicide inducing strategies aimed at preventing stem cell-originated cancerogenesis.
116
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki et al. · Cell · 2007 · 20.2K citations
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Junying Yu, Maxim A. Vodyanik, Kim Smuga-Otto et al. · Science · 2007 · 10.3K citations
Reprogramming of human somatic cells to pluripotency with defined factors
In‐Hyun Park, Rui Zhao, Jason A. West et al. · Nature · 2007 · 2.9K citations
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi, Siok‐Keen Tey, Gianpietro Dotti et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text